Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingObservational

Psychometric and Linguistic Validation of PRO-AYA: Patient-Reported Outcomes for Adolescents and Young Adults (15-39) With Cancer

NCT ID: NCT07212166Sponsor: Memorial Sloan Kettering Cancer CenterLast updated: 2026-05-22

Summary

The purpose of this study is to evaluate a questionnaire called PRO-AYA: Patient-Reported Outcomes for Adolescents and Young Adults.

Arms & interventions

  • OtherPatient-Reported Outcome Surveys

    PRO-AYA , Patient-Reported ECOG PS, EORTC QLQ-C30, Demographic/Clinical Characteristics

  • OtherSpanish version of PRO-AYA and the cognitive interview

    Revised Spanish PRO-AYA, Demographic/Clinical Characteristics

Outcome measures

Primary

  • Test-retest reliability

    The test-retest reliability will be based on the intraclass correlation (ICC) coefficients between the baseline and follow-up domain scores of PRO-AYA.

    Time frame: up to one month

  • Linguistically validate PRO-AYA or patients who prefer their healthcare be delivered in Spanish. (Cohort 2)

    The primary goal of these cognitive interviews is to ensure that the wording and/or phrasing of the instructions, questions and answer choices are appropriate for native Spanish-speakers. The wording and phrasing are a result of direct translation of the English version of the PRO-AYA to a Spanish version.

    Time frame: up to a month

Eligibility criteria

Sex: AllAge: 15 Years to 39 YearsHealthy volunteers: No
Inclusion Criteria: * English- or Spanish proficient o As assessed by two items: How well do you speak English? What is your preferred language for healthcare? * Between the ages of 15-39 * Diagnosed with cancer or the recurrence of a cancer and/or received active treatment for cancer between the ages of 15-39 * Able to complete questionnaires by themselves or with assistance * For Cohort 1 ONLY: * 3 months from last treatment without plan to initiate any form of cancer-directed treatment in the next 3 months OR * On chronic cancer-directed therapy for the last 3 months without plan to change cancer-directed therapy in the next 3 months AND * ECOG Performance Status (0-4) or KPS/Lansky Score (0-100)

Study locations (7)

Memorial Sloan Kettering Basking Ridge (Consent Only)

Basking Ridge, New Jersey, 07920

Recruiting
Thomas Atkinson, PhD · Contact

Memorial Sloan Kettering Monmouth (Consent Only)

Middletown, New Jersey, 07748

Recruiting
Thomas Atkinson, PhD · Contact

Memorial Sloan Kettering Bergen (Consent Only)

Montvale, New Jersey, 07645

Recruiting
Thomas Atkinson, PhD · Contact

Memorial Sloan Kettering Commack (Consent Only)

Commack, New York, 11725

Recruiting
Thomas Atkinson, PhD · Contact

Memorial Sloan Kettering Westchester (Consent Only)

Harrison, New York, 10604

Recruiting
Thomas Atkinson, PhD · Contact

Memorial Sloan Kettering Cancer Center

New York, New York, 10065

Recruiting
Thomas Atkinson, PhD · Contact

Memorial Sloan Kettering Nassau (Consent Only)

Uniondale, New York, 11553

Recruiting
Thomas Atkinson, PhD · Contact
A Study of Questionnaires in Adolescents and Young Adults With Cancer | Cancerify